Prenatal stress affects insulin-like growth factor-1 (IGF-1) level and IGF-1 receptor phosphorylation in the brain of adult rats

European Neuropsychopharmacology

Volumn 24, Issue 9, 2014, Pages 1546-1556

  Basta Kaim, Agnieszka ^a   Szczesny, Ewa ^a   Glombik, Katarzyna ^a   Stachowicz, Katarzyna ^a   Slusarczyk, Joanna ^a   Nalepa, Irena ^a   Zelek Molik, Agnieszka ^a   Rafa Zablocka, Katarzyna ^a   Budziszewska, Boguslawa ^a   Kubera, Marta ^a   Leskiewicz, Monika ^a   Lason, Wladyslaw ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Depression; Forced swim test; IGF 1 receptor; Insulin receptor substrates (IRS 1 2); Insulin like growth factor 1 (IGF 1); Prenatal stress

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; PEPTIDE;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BRAIN HOMOGENATE; BRAIN LEVEL; CLIMBING; CONTROLLED STUDY; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED SWIM TEST; FRONTAL CORTEX; HIPPOCAMPUS; IMMOBILITY; MALE; NONHUMAN; PHYSICAL MOBILITY; PRENATAL STRESS; PRIORITY JOURNAL; PROGENY; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; DRUG EFFECTS; ETIOLOGY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MENTAL STRESS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PREGNANCY; PRENATAL EXPOSURE; PSYCHOLOGY; SPRAGUE DAWLEY RAT; SWIMMING; TIME;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INJECTIONS, INTRAVENTRICULAR; INSULIN-LIKE GROWTH FACTOR I; MALE; PEPTIDES; PHOSPHORYLATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; SWIMMING; TIME FACTORS;

EID: 84907598425     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.07.002     Document Type: Article

References (46)

1. Aguirre V., Uchida T., Yenush L., Davis R.J., White M.F. The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J. Biol. Chem. 2000, 275:9047-9054.
2. Aisa B., Elizalde N., Tordera R., Lasheras B., Del Río J., Ramírez M.J. Effects of neonatal stress on markers of synaptic plasticity in the hippocampus: implications for spatial memory. Hippocampus 2009, 19:1222-1231.
3. Annuziata M., Granata R., Ghigo E. The IGF system. Acta Diabetol. 2011, 48:1-9.
4. Armstrong C.S., Wuarin L., Ishii D.N. Uptake of circulating insulin-like growth factor-I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF-II mRNA content in diabetic rat brain. J. Neurosci. Res. 2000, 59:649-660.
5. Baquedano E., García-Cáceres C., Diz-Chaves Y., Lagunas N., Calmarza-Font I., Azcoitia I., Garcia-Segura L.M., Argente J., Chowen J.A., Frago L.M. Prenatal stress induces long-term effects in cell turnover in the hippocampus-hypothalamus-pituitary axis in adult male rats. PLoS One 2011, 6:e27549.
6. Baserga R., Hongo A., Rubini M., Prisco M., Valentinis B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta 1997, 1332:F105-126.
7. Bondy C.A. Transient IGF-I gene expression during the maturation of functionally related central projection neurons. J. Neurosci. 1991, 11:3442-3455.
8. Branchi I., Francia N., Alleva E. Epigenetic control of neurobehavioural plasticity: the role of neurotrophins. Behav. Pharmacol. 2004, 15:353-362.
9. Budziszewska B., Szymanska M., Leskiewicz M., Basta-Kaim A., Jaworska-Feil L., Kubera M., Jantas D., Lason W. The decrease in JNK- and p38-MAP kinase activity is accompanied by the enhancement of PP2A phosphate level in the brain of prenatally stressed rats. J. Physiol. Pharmacol. 2010, 61:207-215.
10. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
11. Duman R. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromol. Med. 2004, 5:11-25.
12. Duman C.H., Schlesinger L., Terwilliger R., Russell D.S., Newton S.S., Duman R.S. Peripheral insulin-like growth factor-I produces antidepressant-like behaviour and contributes to the effect of exercise. Behav. Brain Res. 2009, 198:366-371.
13. Erabi K., Morinobu S., Kawano K., Tsuji S., Yamawaki S. Neonatal isolation changes the expression of IGF-IR and IGFBP-2 in the hippocampus in response to adulthood restraint stress. Int. J. Neuropsychopharmacol. 2007, 10:369-381.
14. Fagundes C.P., Glaser R., Kiecolt-Glaser J.K. Stressful early life experiences and immune dysregulation across the lifespan. Brain Behav. Immun. 2013, 1:8-12.
15. Gual P., Le Marchand-Brustel Y., Tanti J.F. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005, 87:99-109.
16. Hoshaw B.A., Malberg J.E., Lucki I. Central administration of IGF-I and BDNF leads to long- lasting antidepressant-like activity. Brain Res. 2005, 1037:204-208.
17. Hoshaw B.A., Hill T.I., Crowley J.J., Malberg J.E., Khawaja X., Rosenzweig- Lipson S., Schechter L.E., Lucki I. Antidepressant-like behavioral effects of IGF-1 produced by enhanced serotonin transmission. Eur. J. Pharmacol. 2008, 594:109-116.
18. Khawaja X., Xu J., Liang J.J., Barrett J.E. Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: implications for depressive disorders and future therapies. J. Neurosci. Res. 2004, 75:451-460.
19. Lee K.Y., Miki T., Yokoyama T., Ueki M., Warita K., Suzuki S., Ohta K., Wang Z.Y., Jamal M., Yakura T., Liu J.Q., Hosomi N., Takeuchi Y. Neonatal repetitive maternal separation causes long-lasting alterations in various neurotrophic factor expression in the cerebral cortex of rats. Life Sci. 2012, 90:578-584.
20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
21. Maccari S., Morley-Fletcher S. Effects of prenatal restraint stress on the hypothalamus-pituitary-adrenal axis and related behavioural and neurobiological alterations. Psychoneuroendocrinology 2007, 32(Suppl 1):S10-5.
22. Mairesse J., Silletti V., Laloux C., Zuena A.R., Giovine A., Consolazione M., van Camp G., Malagodi M., Gaetani S., Cianci S., Catalani A., Mennuni G., Mazzetta A., van Reeth O., Gabriel C., Mocaër E., Nicoletti F., Morley-Fletcher S., Maccari S. Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats. Int. J. Neuropsychopharmacol. 2013, 16:323-338.
23. Meyer U., Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog. Neurobiol. 2010, 90:285-326.
24. Mitschelen M., Yan H., Farley J.A., Warrington J.P., Han S., Hereñú C.B., Csiszar A., Ungvari Z., Bailey-Downs L.C., Bass C.E., Sonntag W.E. Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behaviour in adult mice: a potential model of geriatric depression. Neuroscience 2011, 185:50-60.
25. Moloney A.M., Griffin R.J., Timmons S., O'Connor R., Ravid R., O'Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signaling. Neurobiol. Aging 2010, 31:224-243.
26. Morley-Fletcher S., Darnaudery M., Koehl M., Casolini P., Van Reeth O., Maccari S. Prenatal stress in rats predicts immobility behaviour in the forced swim test. Effects of a chronic treatment with tianeptine. Brain Res. 2003, 989:246-251.
27. Morley-Fletcher S., Darnaudery M., Mocaer E., Froger N., Lanfumey L., Laviola G., Casolini P., Zuena A.R., Marzano L., Hamon M., Maccari S. Chronic treatment with imipramine reverses immobility behaviour, hippocampal corticosteroid receptors and cortical 5-HT(1A) receptor mRNA in prenatally stressed rats. Neuropharmacology 2004, 47:841-847.
28. de Pablo F., de la Rosa E.J. The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors. Trends Neurosci. 1995, 18:143-150.
29. Palomino A., González-Pinto A., Martinez-Cengotitabengoa M., Ruiz de Azua S., Alberich S., Mosquera F., Matute C. Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 44C:29-33.
30. Park S.E., Lawson M., Dantzer R., Kelley K.W., McCusker R.H. Insulin-like growth factor-I pepides act centrally to decrease depression-like behaviour of mice treated intraperitoneally with lipopolisaccharide. J. Neuroinflamm. 2011, 8:179.
31. Paz K., Hemi R., LeRoith D., Karasik A., Elhanany E., Kanety H., Zick Y. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J. Biol. Chem. 1997, 272:29911-29918.
32. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, San Diego. 2nd ed.
33. Rao U., McGinty D.J., Shinde A., McCracken J.T., Poland R.E. Prenatal stress is associated with depression-related electroencephalographic sleep changes in adult male rats: a preliminary report. Prog. Neuropsychopharmacol. Biol. Psychiatry 1999, 23:929-939.
34. Rui L., Aguirre V., Kim J.K., Shulman G.I., Lee A., Corbould A., Dunaif A., White M.F. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J. Clin. Invest. 2001, 107:181-189.
35. Russo V.C., Gluckman P.D., Feldman E.L., Werther G.A. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr. Rev. 2005, 6:916-943.
36. Schilling C., Blum W.F., Heuser I., Paslakis G., Deuschle M. Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid. J. Clin. Psychopharmacol. 2011, 31:390-392.
37. Soos M.A., Navé B.T., Siddle K. Immunological studies of type I IGF receptors and insulin receptors: characterisation of hybrid and atypical receptor subtypes. Adv. Exp. Med. Biol. 1993, 343:145-157.
38. Szymanska M., Budziszewska B., Jaworska-Feil L., Basta-Kaim A., Kubera M., Leśkiewicz M., Geront A., Kroczka S., Kacinski M., Lason W. The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats. Psychoneuroendocrinology 2009, 34:822-832.
39. Takahashi L.K., Turner J.G., Kahn N.H. Prenatal stress alters brain catecholaminergic activity and potentiates stress-induced behaviour in adult rats. Brain Res. 1992, 574:131-137.
40. Tanti J.F., Jager J. Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr. Opin. Pharmacol. 2009, 9:753-762.
41. Torres-Aleman I. Toward a comprehensive neurobiology of IGF-I. Dev. Neurobiol. 2010, 70:384-396.
42. Weber-Haman B., Blum W.F., Kratzsch J., Gilles M., Heuser I., Deuschle M. Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment. Pharmacopsychiatry 2009, 42:23-28.
43. Werner E.D., Lee J., Hansen L., Yuan M., Shoelson S.E. Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302. J. Biol. Chem. 2004, 279:35298-35305.
44. White M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E413-E422.
45. White M.F. Regulating insulin signaling and beta-cell function through IRS proteins. Can. J. Physiol. Pharmacol. 2006, 84:725-737.
46. Zick Y. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci. STKE 2005, 268:pe4.